Disease Suppression Persists With Ozanimod at 72 Weeks in MS Helwick C, Medscape, 20 Feb 2016 Accessed on 23 Feb 2016 from http://www.medscape.com/viewarticle/859170#vp_1. CommentRecommendBookmarkWatch